Delivery Order SPE2DR25D6028-SPE2DR26FARAM
- Not listed
- The Defense Logistics Agency awarded a $1,810.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Qsymia 11.25 mg-69 mg capsules (30-count), a prescription weight management medication. The order was competitively awarded with no set-aside designation and is scheduled for completion by August 18, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,876.52 to AmerisourceBergen Drug Corp for the supply of Qsymia 7.5 mg-46 mg capsules (30-count units), a prescription medication used in weight management treatment. The contract, which was competitively awarded with no set-aside designation, was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, utilizing...
- The Defense Logistics Agency awarded a $1,547.92 delivery order to AmerisourceBergen Drug Corp for QSYMIA 7.5 MG-46 MG capsules (30-count units), a pharmaceutical product used in weight management treatment. This competitively awarded, firm fixed-price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for $1,225.31 on June 5, 2025, for the supply of Qsymia 3.75 mg-23 mg capsules (30-count package). This is a non-set-aside competitive award with an ultimate completion date of June 6, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $1,646.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Qsymia 7.5 mg-46 mg capsules (30-count) under contract 4569035131. The delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-set-aside, competitively awarded procurement. Performance will be executed from the vendor's Conshohocken, Pennsylvania location, which serves as the company's corporate office and...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Qsymia 15mg-92mg in 30-count packages, with a ceiling value of $2,738.80. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract is performable in Conshohocken, Pennsylvania, with an ultimate completion date of June 17, 2025, and represents a child delivery order under a larger...
- The Defense Logistics Agency awarded a delivery order valued at $10,555.98 to AmerisourceBergen Drug Corp for the supply of Qsymia 15 mg-92 mg capsules (30-count packaging) under a firm fixed-price contract. The award, issued on October 27, 2025, with an ultimate completion date of October 28, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $4,444.52 to AmerisourceBergen Drug Corp for the supply of Qsymia 15 mg–92 mg capsules (30-count) on September 16, 2025, with completion targeted for September 17, 2025. This firm fixed-price delivery order utilizes no set-aside designation and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be performed at the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Qsymia 7.5 mg-46 mg capsules (30-count) with a ceiling value of $1,137.74 under firm fixed-price terms. The award is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Performance will be completed by...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Qsymia 11.25 mg-69 mg capsules (30-count) valued at $1,614.09, with an ultimate completion date of September 26, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FARAMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,208.14 to AmerisourceBergen Drug Corp for the supply of Qsymia 7.5mg-46mg (30-count), a prescription weight-management medication. The contract, executed on October 28, 2025, with completion scheduled for October 29, 2025, utilizes firm fixed-price pricing and represents a non-set-aside competitive award. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle extending through December 2026. The parent IDC serves as a comprehensive procurement vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems worldwide, including supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities. The award reflects the contractor's demonstrated capability to fulfill federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 10/28/25 |